PCI – 7th June 2024
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Cormica Banner Ad – 24.02.2025
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42

Trusted global partner providing premium elastomeric closure systems for injectables

Driven by quality, service and innovation for more than 50 years, Aptar Stelmi is a trusted partner of leading pharmaceutical and biopharmaceutical companies throughout the world. We design and manufacture elastomeric closures: stoppers for vials, and prefilled syringe and cartridge components such as plungers, needle shields and tip caps for all parenteral applications.
A member of the AptarGroup, we benefit from the global market presence, innovation and technical capabilities of an industry leader.
PremiumCoat™ The alternative coated stopper for sensitive drugs
PremiumCoat™ is a novel range of elastomeric stoppers developed by Aptar Stelmi launched earlier this year. Based on an approved, pure, state-of-the-art formulation, the surface of the elastomer is coated during manufacturing with an ETFE film. This coating acts as an effective barrier to many of the extractables and leachables that can be released from the elastomer. As a result, compatibility of the drug and the closure is significantly superior with PremiumCoat™ stoppers.
Info at aptarstelmi@aptar.com
www.aptarstelmi.com

Stoelzle Skyscraper: 27th November 2024
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35